PMID- 32509880 OWN - NLM STAT- MEDLINE DCOM- 20210405 LR - 20220414 IS - 2314-6753 (Electronic) IS - 2314-6745 (Print) VI - 2020 DP - 2020 TI - Lactobacillus plantarum And Inulin: Therapeutic Agents to Enhance Cardiac Ob Receptor Expression and Suppress Cardiac Apoptosis in Type 2 Diabetic Rats. PG - 4745389 LID - 10.1155/2020/4745389 [doi] LID - 4745389 AB - BACKGROUND: T2DM may cause increased levels of oxidative stress and cardiac apoptosis through elevated blood glucose. The present study investigated the effects of Lactobacillus plantarum (L. plantarum) as a probiotic strain and inulin as a prebiotic supplement on cardiac oxidative stress and apoptotic markers in type 2 diabetes mellitus (T2DM) rats. METHODS: A high-fat diet and a low dose of streptozotocin were used to induce type 2 diabetes. The rats were divided into six groups which were supplemented with L. plantarum, inulin, or their combination for 8 weeks. RESULTS: The results showed improved activity of cardiac antioxidant parameters including total antioxidant capacity (TAC), superoxide dismutase (SOD), and glutathione peroxidase (GPx) (P < 0.001, P < 0.01, and P < 0.01, respectively) and decreased level of cardiac malondialdehyde (MDA) concentration (P < 0.05). These changes were accompanied with increased protein expression of cardiac obesity receptor (Ob-R) (P = 0.05) and reduced apoptotic markers such as tumor necrosis factor-alpha (TNF-alpha), Fas ligand (FasL), and caspase proteins (P < 0.001, P = 0.003, and P < 0.01, respectively) in T2DM rats after concurrent L. plantarum and inulin supplementation. Moreover, a remarkable correlation of cardiac Ob-R and oxidative stress parameters with cardiac apoptotic markers was observed (P < 0.01). CONCLUSION: The concurrent use of L. plantarum and inulin seems to be beneficial, as they can lead to decreased heart complications of T2DM via reducing cardiac apoptotic markers. CI - Copyright (c) 2020 Safa Sefidgari-Abrasi et al. FAU - Sefidgari-Abrasi, Safa AU - Sefidgari-Abrasi S AUID- ORCID: 0000-0003-2475-9073 AD - Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. AD - Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. AD - Nutrition Research Center, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Karimi, Pouran AU - Karimi P AD - Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Roshangar, Leila AU - Roshangar L AD - Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Morshedi, Mohammad AU - Morshedi M AD - Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Bavafa-Valenlia, Khadijeh AU - Bavafa-Valenlia K AD - Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. AD - Nutrition Research Center, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Saghafi-Asl, Maryam AU - Saghafi-Asl M AUID- ORCID: 0000-0002-6658-2918 AD - Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. AD - Nutrition Research Center, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. AD - Department of Clinical Nutrition, School of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Mohiti, Sara AU - Mohiti S AD - Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. AD - Nutrition Research Center, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Rahimiyan-Heravan, Marziyeh AU - Rahimiyan-Heravan M AD - Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. AD - Nutrition Research Center, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. LA - eng PT - Journal Article DEP - 20200515 PL - England TA - J Diabetes Res JT - Journal of diabetes research JID - 101605237 RN - 0 (Blood Glucose) RN - 0 (Receptors, Leptin) RN - 9005-80-5 (Inulin) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Blood Glucose/drug effects/metabolism MH - Diabetes Mellitus, Experimental/*diet therapy/metabolism/pathology MH - Diabetes Mellitus, Type 2/diet therapy/metabolism/pathology MH - Diabetic Cardiomyopathies/pathology/*prevention & control MH - Dietary Supplements MH - Heart/drug effects/*physiology MH - Inulin/*administration & dosage MH - *Lactobacillus plantarum MH - Male MH - Myocardium/metabolism/pathology MH - Oxidative Stress/drug effects MH - Probiotics/administration & dosage MH - Rats MH - Rats, Wistar MH - Receptors, Leptin/*metabolism PMC - PMC7246403 COIS- The authors declare that they have no competing interests. EDAT- 2020/06/09 06:00 MHDA- 2021/04/07 06:00 PMCR- 2020/05/15 CRDT- 2020/06/09 06:00 PHST- 2020/01/31 00:00 [received] PHST- 2020/04/23 00:00 [accepted] PHST- 2020/06/09 06:00 [entrez] PHST- 2020/06/09 06:00 [pubmed] PHST- 2021/04/07 06:00 [medline] PHST- 2020/05/15 00:00 [pmc-release] AID - 10.1155/2020/4745389 [doi] PST - epublish SO - J Diabetes Res. 2020 May 15;2020:4745389. doi: 10.1155/2020/4745389. eCollection 2020.